- Home
- NVAX vs DHT Comparison
NVAX vs DHT Comparison
Compare NVAX & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- DHT
- Stock Information
- Founded
- NVAX 1987
- DHT 2005
- Country
- NVAX United States
- DHT Bermuda
- Employees
- NVAX N/A
- DHT N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- DHT Marine Transportation
- Sector
- NVAX Health Care
- DHT Consumer Discretionary
- Exchange
- NVAX Nasdaq
- DHT Nasdaq
- Market Cap
- NVAX 1.3B
- DHT 1.6B
- IPO Year
- NVAX 1995
- DHT 2005
- Fundamental
- Price
- NVAX $6.76
- DHT $10.96
- Analyst Decision
- NVAX Buy
- DHT Strong Buy
- Analyst Count
- NVAX 5
- DHT 4
- Target Price
- NVAX $16.60
- DHT $13.75
- AVG Volume (30 Days)
- NVAX 5.3M
- DHT 1.9M
- Earning Date
- NVAX 08-07-2025
- DHT 08-11-2025
- Dividend Yield
- NVAX N/A
- DHT 8.67%
- EPS Growth
- NVAX N/A
- DHT 4.76
- EPS
- NVAX 2.97
- DHT 1.10
- Revenue
- NVAX $1,254,962,000.00
- DHT $563,104,000.00
- Revenue This Year
- NVAX $56.85
- DHT N/A
- Revenue Next Year
- NVAX N/A
- DHT $26.57
- P/E Ratio
- NVAX $2.27
- DHT $9.81
- Revenue Growth
- NVAX 25.92
- DHT N/A
- 52 Week Low
- NVAX $5.01
- DHT $8.67
- 52 Week High
- NVAX $17.81
- DHT $12.32
- Technical
- Relative Strength Index (RSI)
- NVAX 50.89
- DHT 41.78
- Support Level
- NVAX $6.23
- DHT $10.71
- Resistance Level
- NVAX $6.60
- DHT $12.17
- Average True Range (ATR)
- NVAX 0.30
- DHT 0.31
- MACD
- NVAX -0.01
- DHT -0.12
- Stochastic Oscillator
- NVAX 54.78
- DHT 15.31
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. It is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. It generates revenues from time charter and spot market operations. Its fleets consist of very large crude carriers known as VLCCs that range in size from 270,000 to 320,000 deadweight tons. Geographically, DHT operates in Monaco, Oslo, Norway, and Singapore. The company generates the majority of its revenue from the shipping revenues.